Companies / Texas / CNS Pharmaceuticals

· rebuilt nightly from public records

Signal Sheet

Selling to CNS Pharmaceuticals? Who to reach and why now

CNS Pharmaceuticals is a publicly listed pharmaceutical preparations company in Houston, Texas. It raised $22.5M in May 2026 and its filings name 7 officers. Everything below links to the record it came from.

Listed company · Pharmaceutical Preparations · Texas

The easy button for new customers

Lakewave's AI keeps accounts like this one coming. Your pipeline refills while you sleep.

Every night it scans funding, filings, new officers, hiring, contracts, permits and bids, finds the accounts that fit what you sell, and delivers each with outreach and a pursuit plan. Just need a list? Its AI waterfall builds one with verified, reachable contacts.

SourceNew accounts that match what you offer, added as the signals land. The list never runs dry.
Reach outA first email written from why the account is hot, then a drip sequence that follows up until they reply. Sent from your own mailbox, with every open and reply tracked.
PursueAn AI-written plan built from your value proposition and the customer's compelling event: who to call, what to lead with, and the next step to win it. In early access.
Start your free trial →Tell it what you sell and where. Your list stays yours.

Who to reach

The roles that matter for a seller right now. Names on this page come from SEC filings or the company's own announcements. Contacts you find with a free trial are verified before you see them. How we source names

RoleContactSourceWhy they matter now
Executive OfficerRami LevinSEC filing, May 2026Named officer in the filing; part of the buying group
Executive OfficerSteve O'LoughlinSEC filing, May 2026Named officer in the filing; part of the buying group
Chief Technology OfficerFaith CharlesSEC filing, May 2026Technology and tooling decisions
Chief Technology OfficerMichal FisherSEC filing, May 2026Technology and tooling decisions
Chief Technology OfficerJeffry KeyesSEC filing, May 2026Technology and tooling decisions
Chief Technology OfficerBettina CockroftSEC filing, May 2026Technology and tooling decisions
Chief Technology OfficerAmy MaherySEC filing, May 2026Technology and tooling decisions
For sellersWhy CNS Pharmaceuticals is worth a call this quarterBuy Window: open · new leadership Sep 2026
Sep 30Sep 2026

New leadership

Officer or director change

New leadership
$22.5M

Raised

Equity raise reported to the SEC, May 2026. Money arrives before the spending plan does.

Capital
7officers

Named in filings

Each with a title and the filing that names them, so the first call goes to the right desk.

People
Track CNS Pharmaceuticals with a free trial →Get the next signal the day it is filed or posted.
Email me the next CNS Pharmaceuticals signalOne email when it files, raises, hires or posts a role. Watch up to 3 companies free, no password.

Why now

The most recent events first, refreshed every night. Each links to the record it came from.

WhenWhat happenedKindSource
Sep 30, 2026Officer or director changeNew leadershipSEC filing
May 4, 2026Raised $22.5M in equity from 13 investorsCapitalSEC filing

Reach CNS Pharmaceuticals with emails that land

Lakewave finds the right people at CNS Pharmaceuticals, checks every address against the mail server before you see it, and drafts a first email for each, which you review and send from your own inbox.

Try it on CNS Pharmaceuticals with a free trial →

About CNS Pharmaceuticals

HeadquartersHouston, Texas, per the filing address
Industry groupPharmaceutical Preparations
OwnershipListed company
Raise history$22.5M (May 2026)
Lakewave Rising9 · 2 kinds of evidence · rank in Texas after sign-up

Similar companies

Private-sector companies in the same industry group and state, ranked by Rising score.

Actuate Therapeutics · 50Tivic Health Systems · 35Salarius Pharmaceuticals · 34Cerenome · 33Sensei Biotherapeutics · 17See all 5 with a free trial →

Questions people ask

Did CNS Pharmaceuticals raise funding in 2026?

Yes. CNS Pharmaceuticals reported a $22.5M equity raise to the SEC on May 4, 2026 with 13 investors.

Who runs CNS Pharmaceuticals?

The company's SEC filing, May 2026 names Rami Levin (Executive Officer) among its officers.

Where is CNS Pharmaceuticals headquartered?

Houston, Texas, per the address on its SEC filing.

Know who is buying before the first callStart your free trial →

Know who is buying before the first call

Select the accounts and territory you sell to and get dated reasons for every company: new budget, new leaders, new hires, with who to reach and a first draft for each contact.

Start your free trial

Compiled from public records and refreshed nightly; last updated Nov 16, 2026. Facts are as the SEC, the company's careers page or the company's own announcements published them. Check the source before acting. See something wrong? Tell us and we will correct it.